RA Chem Pharma Limited

RA Chem Pharma Limited is a vertically integrated pharmaceutical company that, over the past 10 years, has expanded by establishing state-of-the-art manufacturing facilities in API, formulations and clinical research. The company operates three divisions: an API division manufacturing niche APIs, intermediates and custom synthesis under cGMP in facilities approved by the US FDA, EDQM, KFDA (Korea), PMDA (Japan) and COFEPRIS (Mexico); a formulation division developing and manufacturing pharmaceutical products using advanced drug delivery systems with emphasis on sustained release under cGMP conditions in facilities approved by the US FDA, UK MHRA, COFEPRIS (Mexico) and MOH (Iran); and a BA/BE division undertaking full-service contract research in bioavailability and bioequivalence at a US FDA-approved facility.